PAACT Inc
Free Prostate Cancer Newsletter Signup
  • Home
  • DONATIONS
  • NEWSLETTER
  • BLOG
  • GALLERY
  • ABOUT US
    • President & CEO
    • Our Team
    • Founder
    • Mission & Vision
    • Achievements / Milestones & Awards
    • Board of Directors
    • Honorary Board Members
    • Medical Advisory Board
    • Contributing Vendors
  • CONTACT US
Home » Archives for Paactusa
image_print

PSA Screening – Where are we now?

July 25, 2016 by Paactusa

by Jan Manarite, VP of Advocacy & Education Lonnie Silva’s story (Click here) of having to ask for a PSA blood test for almost 10 years, just to get a baseline and screen for prostate cancer is frustrating to read.  Even more frustrating is that his first PSA came in at 22.1 after being … [Read more...]

Filed Under: Prostate Cancer Tagged With: PSA, U.S. Preventive Services Task Force, PSA Screening, USPSTF, Task Force, Informed Decision Making, 2016

My Prostate Cancer Story: Avid Reader Becomes Advocate

July 25, 2016 by Paactusa

By Lonnie Silva As I approached my mid-50s, I enjoyed reading well respected American publications. As an avid reader, I was never one for subscribing to rag sheets or the infamous tabloids. One subject on my reading list was prostate cancer. Through my research, I discovered a new blood test … [Read more...]

Filed Under: Prostate Cancer

New PET Scan Approved for Prostate Cancer – for PSA Recurrence After Treatment

June 10, 2016 by Paactusa

  On May 27, 2016, the FDA approved a new PET Scan tracer (injection) for prostate cancer patients with “suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.” (1)  There are several names for this new PET imaging agent, but they … [Read more...]

Filed Under: Prostate Cancer

Focal Therapy – Brief Overview and Focal Cryo Experience at PIOA

May 3, 2016 by Paactusa

Duke K. Bahn, MD • Prostate Institute of America (www.PIOA.ORG) • Ventura, California (805) 585-3082  or  (888) 234-0004     INTRODUCTION: The progression of clinically localized prostate cancer is usually slower than other cancers, and has confounded the development of a … [Read more...]

Filed Under: Prostate Cancer, Newly Diagnosed & Active Surveillance Tagged With: Bahn, newly diagnosed, Cryo, laser, focal, IRE, HIFU, Doppler, nanoknife

Some Current Trials – In the Field of Biomarkers

April 22, 2016 by Paactusa

Clinical trials are constantly changing. But to offer our readers some current options that might be worth researching, here is what I found for clinical trials using BRCA testing, or AR-V7 testing – both of which are mentioned in Dr Eshaghian’s article here.     CURRENT TRIALS IN … [Read more...]

Filed Under: Paactusa Tagged With: clinical trials, galeterone, AR-V7, BRCA, Niclosamide, STARVE-PC, LY2606368, BMN 673, PARP Inhibitor, olaparib, lynparza

On the Horizon-Individualized Biomarker Driven Therapy for CRPC

April 22, 2016 by Paactusa

By Shahrooz Eshaghian, MD FACP • Compassionate Oncology Medical Group Clinical Instructor UCLA School of Medicine • Attending Physician, Division of Hematology & Oncology at Cedars Sinai Medical Center eshaghian@compassionateoncology.org   The past decade has brought many advances … [Read more...]

Filed Under: Paactusa Tagged With: clinical trials, mCRPC, galeterone, AR-V7, BRCA, Niclosamide, STARVE-PC, LY2606368, BMN 673, PARP Inhibitor, olaparib, lynparza, Foundation One, Eshaghian

Adding Prednisone to Zytiga – More Side Effects?

April 14, 2016 by Paactusa

I have heard a few prostate cancer patients comment that they are worried about taking Zytiga (abiraterone) because they are concerned about the side effects of the 5 mg prednisone ( 2 x day) which is prescribed with the Zytiga.  People who have been on prednisone for other reasons (gout, arthritis, … [Read more...]

Filed Under: Paactusa, PSA Rising (On Hormone Therapy), Caregivers Tagged With: abiraterone, Zytiga, prednisone, pharmacist, side effects, corticosteroid, Gomella, specialty pharmacy

AR-V7 Blood Test now Available – for mCRPC Patients

March 11, 2016 by Paactusa

The AR-V7 blood test may help patients and doctors make decisions on treatment choices when prostate cancer patients are metastatic, and castrate resistant, or mCRPC.  The term AR-V7 stands for androgen-receptor splice variant 7.  This blood test recently became available to the public through Johns … [Read more...]

Filed Under: PSA Rising (On Hormone Therapy) Tagged With: mCRPC, CRPC, metastatic, AR-V7, castrate-resistant, blood test

Dr Fred Lee, 1930 – 2016

January 21, 2016 by Paactusa

PAACT mourns the loss of Dr Fred Lee, the Father of color Doppler ultrasound for prostate, and a pioneer in cryotherapy in the USA.  He was a true advocate at heart, and helped hundreds of patients in his clinic in Rochester, Michigan.   Dr Lee often joked that his close friend Dr Duke … [Read more...]

Filed Under: Paactusa Tagged With: Fred Lee, Cryo, color Doppler, obituary, Duke Bahn, memorial, ann arbor

Winter 2015, Article 71

December 8, 2015 by Paactusa

What the Heck Has Been Going on in My World? By Mark A. Moyad, MD, MPH, University of Michigan article #71 – Winter 2015 Note: A total of 71 (YES THAT IS 71…that’s a lot...even higher than the number of times my kids said "I am sorry and I will not do that again" and then they did that again!) … [Read more...]

Filed Under: Paactusa Tagged With: PSA Screening, cholesterol, heart healthy, prostate healthy, diet, vitamin D, D3, calcium, supplement handbook, diabetes, sodium, fiber, coffee, chemo, chemotherapy, pomegranate, acid reflux, blood sugar, blood pressure, fast food, egg white, calories, protein, falls, kidney stones, CVD, heart, Metamucil, simvastatin, flaxseed, anti-aging, PLCO, USPSTF, Zostavax, shingles vaccine

  • 1
  • 2
  • 3
  • …
  • 38
  • Next Page »

Recent Posts

  • PSA Screening – Where are we now?
  • My Prostate Cancer Story: Avid Reader Becomes Advocate
  • New PET Scan Approved for Prostate Cancer – for PSA Recurrence After Treatment
  • Focal Therapy – Brief Overview and Focal Cryo Experience at PIOA
  • Some Current Trials – In the Field of Biomarkers
  • On the Horizon-Individualized Biomarker Driven Therapy for CRPC
  • Adding Prednisone to Zytiga – More Side Effects?
  • AR-V7 Blood Test now Available – for mCRPC Patients
  • Dr Fred Lee, 1930 – 2016
  • Winter 2015, Article 71

Tags

abiraterone AR-V7 bone scan cholesterol clinical trials CRPC Cryo D3 diet ED exercise Focal therapy heart healthy imaging Incontinence jan manarite manarite mCRPC metastases MRI nerve sparing newly diagnosed Nuclear medicine paact paactusa PET scan Prevention Prostate Cancer prostatectomy prostate healthy Provenge PSA PSA Screening Radiologist screening side effects sleep surgery testosterone Tewari U.S. Preventive Services Task Force vitamin D Xofigo Xtandi Zytiga
Donations | Newsletter | Events | Resources | About Us | Gallery | Blog | Contact Us | Our Team | Privacy
Copyright PAACT Inc. 2019, All Rights Reserved.
  •  
  •  
"Bayer is a Supporting Sponsor For Educational Content of This Website"